First County Bank CT Cuts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

First County Bank CT decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 9.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,405 shares of the healthcare conglomerate’s stock after selling 255 shares during the quarter. First County Bank CT’s holdings in UnitedHealth Group were worth $1,217,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the business. Diversified Trust Co increased its stake in shares of UnitedHealth Group by 14.1% during the fourth quarter. Diversified Trust Co now owns 49,745 shares of the healthcare conglomerate’s stock worth $25,164,000 after purchasing an additional 6,158 shares in the last quarter. Bangor Savings Bank lifted its holdings in UnitedHealth Group by 7.5% in the 4th quarter. Bangor Savings Bank now owns 804 shares of the healthcare conglomerate’s stock valued at $407,000 after purchasing an additional 56 shares in the last quarter. Canandaigua National Trust Co of Florida raised its position in shares of UnitedHealth Group by 16.0% in the fourth quarter. Canandaigua National Trust Co of Florida now owns 875 shares of the healthcare conglomerate’s stock valued at $443,000 after buying an additional 121 shares during the last quarter. Ables Iannone Moore & Associates Inc. boosted its position in UnitedHealth Group by 1.0% during the fourth quarter. Ables Iannone Moore & Associates Inc. now owns 3,848 shares of the healthcare conglomerate’s stock worth $1,947,000 after acquiring an additional 37 shares during the last quarter. Finally, Fortem Financial Group LLC raised its holdings in UnitedHealth Group by 16.7% in the 4th quarter. Fortem Financial Group LLC now owns 818 shares of the healthcare conglomerate’s stock valued at $414,000 after acquiring an additional 117 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms recently commented on UNH. Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. Barclays boosted their price target on shares of UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a research report on Wednesday, November 27th. Oppenheimer lifted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Bank of America cut their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Finally, UBS Group cut their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $627.58.

UnitedHealth Group Stock Up 0.0 %

UnitedHealth Group stock traded up $0.12 during mid-day trading on Tuesday, hitting $513.79. The company had a trading volume of 2,444,094 shares, compared to its average volume of 3,499,273. The business has a fifty day moving average of $558.76 and a 200 day moving average of $561.51. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $472.83 billion, a price-to-earnings ratio of 33.47, a PEG ratio of 1.53 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.56 earnings per share. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.63%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is currently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.